250 related articles for article (PubMed ID: 26908812)
1. Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States.
Jonas MC; Rodriguez CV; Redd J; Sloane DA; Winston BJ; Loftus BC
Clin Infect Dis; 2016 May; 62(10):1290-1296. PubMed ID: 26908812
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States.
Jonas MC; Rubenstein K; Watson E; Basra S; Horberg M
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834947
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
[TBL] [Abstract][Full Text] [Related]
5. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
[TBL] [Abstract][Full Text] [Related]
6. Impact of electronic reminder systems on hepatitis C screening in primary care.
MacLean CD; Berger C; Cangiano ML; Ziegelman D; Lidofsky SD
J Viral Hepat; 2018 Aug; 25(8):939-944. PubMed ID: 29478306
[TBL] [Abstract][Full Text] [Related]
7. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
[TBL] [Abstract][Full Text] [Related]
9. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
Lebovics E; Torres R; Porter LK
Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
[TBL] [Abstract][Full Text] [Related]
10. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
[TBL] [Abstract][Full Text] [Related]
11. A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.
Southern WN; Norton B; Steinman M; DeLuca J; Drainoni ML; Smith BD; Litwin AH
BMC Infect Dis; 2015 Dec; 15():553. PubMed ID: 26626449
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C screening trends in a large integrated health system.
Linas BP; Hu H; Barter DM; Horberg M
Am J Med; 2014 May; 127(5):398-405. PubMed ID: 24486288
[TBL] [Abstract][Full Text] [Related]
13. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
[TBL] [Abstract][Full Text] [Related]
14. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
15. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
16. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
[TBL] [Abstract][Full Text] [Related]
17. Validation of a hepatitis C screening tool in primary care.
McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
